These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 24795243)

  • 1. Definition and management of radioactive iodine-refractory differentiated thyroid cancer.
    Schlumberger M; Brose M; Elisei R; Leboulleux S; Luster M; Pitoia F; Pacini F
    Lancet Diabetes Endocrinol; 2014 May; 2(5):356-8. PubMed ID: 24795243
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of radioactive iodine in patients with papillary and follicular thyroid cancer.
    Wartofsky L; Sherman SI; Gopal J; Schlumberger M; Hay ID
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4195-203. PubMed ID: 9851751
    [No Abstract]   [Full Text] [Related]  

  • 3. [CME: Radioactive iodine therapy in thyroid cancer].
    Steinert HC; Aberle S
    Praxis (Bern 1994); 2015 Nov; 104(23):1235-43; quiz 1244-5. PubMed ID: 26558927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodine-refractory differentiated thyroid cancer: an ominous diagnosis with the potential for a brighter future.
    Sipos JA; Kloos RT
    Clin Adv Hematol Oncol; 2008 Oct; 6(10):767-9. PubMed ID: 18997668
    [No Abstract]   [Full Text] [Related]  

  • 5. Emerging Therapies for Radioactive Iodine Refractory Thyroid Cancer.
    Kirtane K; Roth MY
    Curr Treat Options Oncol; 2020 Feb; 21(3):18. PubMed ID: 32048061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspective: The Molecular Landscape of Radioactive Iodine Refractory Differentiated Thyroid Cancer and Poorly Differentiated Thyroid Cancer.
    Shobab L; Wartofsky L
    Thyroid; 2023 Feb; 33(2):138-142. PubMed ID: 36345225
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-iodine diet in the treatment of differentiated thyroid cancer with radioactive iodine.
    Sonenberg M
    Endocrine; 2002 Mar; 17(2):141-3. PubMed ID: 12041916
    [No Abstract]   [Full Text] [Related]  

  • 8. Challenges in the evaluation and management of radioactive iodine-refractory differentiated thyroid cancer.
    Genco MT; Yaqub A; Jana S
    Nucl Med Commun; 2022 Jul; 43(7):743-745. PubMed ID: 35438680
    [No Abstract]   [Full Text] [Related]  

  • 9. Initial radioiodine administration: when to use it and how to select the dose.
    Esposito G
    Endocrinol Metab Clin North Am; 2014 Jun; 43(2):385-400. PubMed ID: 24891168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiated thyroid cancer: lobectomy and radioiodine, a treatment suitable for all cases?
    Allan E; Owens SE; Waller ML
    Nucl Med Commun; 1999 Nov; 20(11):983-9. PubMed ID: 10572907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Therapeutics in Radioactive Iodine-Resistant Thyroid Cancer.
    Fullmer T; Cabanillas ME; Zafereo M
    Front Endocrinol (Lausanne); 2021; 12():720723. PubMed ID: 34335481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiated thyroid cancer: an update.
    Wang TS; Roman SA; Sosa JA
    Curr Opin Oncol; 2011 Jan; 23(1):7-12. PubMed ID: 20861795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presentation and practical management to optimize radioiodine treatment of well differentiated thyroid cancer: ablation of thyroid remnants with radioiodine.
    Janisch A; Altenbrunn HJ; Markwardt J
    Radiobiol Radiother (Berl); 1987; 28(5):707-10. PubMed ID: 3441634
    [No Abstract]   [Full Text] [Related]  

  • 14. Radioactive iodine treatment for differentiated thyroid carcinoma in Japan.
    Okamoto T
    Surgery; 2010 Mar; 147(3):432-3. PubMed ID: 20176244
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
    Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
    Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of radiotherapy and radioactive iodine in the treatment of thyroid cancer without metastases.
    Tubiana M; Charbord P; Cukersztein W; Sarrazin D; Fontaine F; Parmentier C
    Ann Radiol (Paris); 1977; 20(8):801-9. PubMed ID: 610552
    [No Abstract]   [Full Text] [Related]  

  • 17. [Advanced radioiodine-refractory differentiated thyroid cancer].
    Spitzweg C; Auernhammer CJ; Geisler J; Böck S; Heinemann V; Bartenstein P; Göke B
    Dtsch Med Wochenschr; 2015 Feb; 140(3):168-71. PubMed ID: 25658401
    [No Abstract]   [Full Text] [Related]  

  • 18. MERAIODE: A Phase II Redifferentiation Trial with Trametinib and
    Leboulleux S; Benisvy D; Taieb D; Attard M; Bournaud C; Terroir-Cassou-Mounat M; Lacroix L; Anizan N; Schiazza A; Garcia ME; Ghuzlan AA; Lamartina L; Schlumberger M; Godbert Y; Borget I
    Thyroid; 2023 Sep; 33(9):1124-1129. PubMed ID: 37350119
    [No Abstract]   [Full Text] [Related]  

  • 19. Current controversies in the initial post-surgical radioactive iodine therapy for thyroid cancer: a narrative review.
    Blumhardt R; Wolin EA; Phillips WT; Salman UA; Walker RC; Stack BC; Metter D
    Endocr Relat Cancer; 2014; 21(6):R473-84. PubMed ID: 25277792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid cancer guidelines--what's new?
    Gerrard G; Gill V
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):264-6. PubMed ID: 18343311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.